Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H9F5N2O3 |
InChIKeyKMHKOOKREYIIBC-UHFFFAOYSA-N |
CAS Registry2494082-34-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myeloid Leukemia | Preclinical | CA | 01 Sep 2020 |